Liv Pure Peptide Product: Tb-500

Liv Pure Peptides Tb-500 (THYMOSIN BETA-4) Categories: Recovery & Healing, Anti Aging $110.00 CAS# 77591-33-4 Formula: C212H350N56O78S Molecular Weight: 4963.000 g/mol

TB-500, a synthetic form of Thymosin Beta-4, is a 43 amino acid peptide frequently used in research examining tissue repair and regenerative processes. This compound has been explored in various models for its potential to enhance blood vessel growth, facilitate wound healing, and modulate inflammation. Its roles in tissue protection, regeneration, and remodeling—especially in the context of heart and central nervous system studies—also make it of interest in anti-aging research.

Offered in a stable lyophilized powder form, TB-500 is available exclusively for research and development purposes.

Sizes

5 mg

View COA: 20250321

At Liv Pure Peptides, innovation meets purity. Our advanced research and rigorous quality standards deliver breakthrough peptide solutions for better health and science.

Shop Products

Products

Pages

Legal

Newsletter Signup

YOU MUST BE OVER 21 YEARS OLD TO USE THIS WEBSITE.

All products provided by Liv Pure are intended solely for in‑vitro laboratory research purposes. These materials are expressly forbidden for any form of human or animal use, ingestion, or administration, and all products are sold strictly for research, laboratory, or analytical purposes – not for human consumption.

The products offered on this platform are not formulated, designed, or intended to diagnose, cure, mitigate, treat, or prevent any diseases or medical conditions. Additionally, these statements have not been evaluated by the Food and Drug Administration, and our products are not intended to diagnose, treat, cure, or prevent any disease.

All products are for Research and Development use only and are not for human consumption.

Liv Pure is a chemical supplier; LIV Pure Peptides is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor is it an outsourcing facility as defined under Section 503B of the Act.